Overview
Agilent Technologies, Inc., based in the United States, is a prominent player in the analytical laboratory instrument manufacturing industry. The company excels in developing a wide range of instruments, services, and consumables used in laboratories across the globe. Noteworthy pursuits include innovations in life sciences, diagnostics, and applied chemical markets. Key projects by Agilent focus on high-precision instruments like chromatographs, spectrometers, and genomics and pathology workflows that support complex analytical laboratory operations. This niche expertise aids in extending research capabilities in various scientific sectors, contributing significantly to advancements in health and technology sectors by providing critical analytical tools and technologies necessary for complex data analysis and experimentation.
Basic Stats
The share price of Agilent Technologies, Inc. as of September 5, 2025 is $128.78 / share. This is an increase of 2.48% from the prior week. The market cap (or net worth) of Agilent Technologies, Inc. as of September 5, 2025 is $36,519.80 MM.
The Factor Analysis chart (below right) shows a view of Agilent Technologies, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 36,519.80 MM |
| EV | 38,397.80 MM |
| Shares Out. | 283.59 MM |
| Earnings Date | |
| EPS (TTM) | 4.30 |
| Dividend Yield | 0.77 % |
| Ex-Dividend Date | 2025-07-01 |
| Borrow Rate | 0.25 |
| Short Shares Avail. | 4.60 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | -6.93 % |
| Volatility (1 yr) | 0.31 |
| Beta | 0.85 |
| Sharpe Ratio (1 yr) | -0.36 |
| Sortino Ratio (1 yr) | -0.61 |
| PE Ratio | 29.93 |
| Price/Book | 5.73 |
| Price/TBV | 25.61 |
| Book/Market | 0.17 |
| EBIT/EV | 0.04 |
| EBIT(3yr avg)/EV | 0.04 |
| ROA | 0.11 |
| ROE | 0.21 |
| ROIC | 0.12 |
| CROIC | -0.02 |
| OCROIC | 0.15 |
| Implied Volatility | 27.23 % |
| Put/Call OI Ratio | 0.75 |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Agilent Technologies, Inc. is $136.72. The forecasts range from a low of $121.20 to a high of $158.55. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Agilent Technologies, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-10 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2023-01-06 | SVB Leerink | Outperform | Maintains | |
| 2022-12-20 | UBS | Buy | Maintains | |
| 2022-11-22 | SVB Leerink | Outperform | Maintains | |
| 2022-11-22 | Keybanc | Overweight | Maintains | |
| 2022-11-22 | Citigroup | Neutral | Maintains | |
| 2022-08-25 | Credit Suisse | Outperform | Initiate | |
| 2022-08-17 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-08-17 | Citigroup | Neutral | Maintains | |
| 2022-08-17 | Baird | Outperform | Maintains | |
| 2022-08-17 | B of A Securities | Buy | Maintains | |
| 2022-07-20 | UBS | Buy | Initiate | |
| 2022-07-14 | Goldman Sachs | Buy | Maintains | |
| 2022-07-08 | Citigroup | Buy | Neutral | Downgrade |
| 2022-06-02 | Keybanc | Overweight | Maintains | |
| 2022-05-25 | Baird | Outperform | Maintains | |
| 2022-04-25 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2022-02-23 | Wells Fargo | Overweight | Maintains | |
| 2022-02-23 | SVB Leerink | Outperform | Maintains | |
| 2022-02-23 | Stifel | Hold | Maintains | |
| 2022-02-23 | Citigroup | Buy | Maintains | |
| 2021-11-23 | SVB Leerink | Outperform | Maintains | |
| 2021-09-17 | Cowen & Co. | Outperform | Maintains | |
| 2021-08-18 | Wells Fargo | Overweight | Maintains | |
| 2021-08-18 | SVB Leerink | Outperform | Maintains | |
| 2021-08-18 | Stifel | Hold | Maintains | |
| 2021-08-18 | Keybanc | Overweight | Maintains | |
| 2021-08-18 | Jefferies | Buy | Maintains | |
| 2021-08-18 | Baird | Outperform | Maintains | |
| 2021-07-12 | Keybanc | Overweight | Maintains | |
| 2021-05-26 | Wells Fargo | Overweight | Maintains | |
| 2021-05-26 | SVB Leerink | Outperform | Maintains | |
| 2021-05-26 | Keybanc | Overweight | Maintains | |
| 2021-05-26 | Citigroup | Buy | Maintains | |
| 2021-05-26 | Baird | Outperform | Maintains | |
| 2021-03-18 | Citigroup | Neutral | Buy | Upgrade |
| 2021-02-17 | Wells Fargo | Overweight | Maintains | |
| 2021-02-17 | SVB Leerink | Outperform | Maintains | |
| 2021-02-17 | KeyBanc | Overweight | Maintains | |
| 2021-02-17 | Cowen & Co. | Outperform | Maintains | |
| 2021-02-17 | Citigroup | Neutral | Maintains | |
| 2021-02-17 | Baird | Outperform | Maintains | |
| 2020-12-10 | SVB Leerink | Outperform | Maintains | |
| 2020-11-25 | UBS | Neutral | Buy | Upgrade |
| 2020-11-24 | SVB Leerink | Outperform | Maintains | |
| 2020-11-10 | KeyBanc | Overweight | Initiate | |
| 2020-08-19 | Citigroup | Neutral | Maintains | |
| 2020-07-20 | B of A Securities | Neutral | Maintains | |
| 2020-05-25 | UBS | Neutral | Maintains | |
| 2020-05-22 | Wells Fargo | Overweight | Maintains | |
| 2020-05-22 | UBS | Neutral | Maintains | |
| 2020-05-22 | SVB Leerink | Outperform | Maintains | |
| 2020-05-22 | CFRA | Hold | Maintains | |
| 2020-05-22 | B of A Securities | Neutral | Maintains | |
| 2020-04-28 | UBS | Neutral | Maintains | |
| 2020-04-02 | Stifel | Hold | Maintains | |
| 2020-03-30 | Wells Fargo | Overweight | Maintains | |
| 2020-03-26 | Barclays | Equal-Weight | Maintains | |
| 2020-03-20 | Citigroup | Neutral | Maintains | |
| 2020-02-24 | Needham | Buy | Hold | Downgrade |
| 2020-02-19 | UBS | Neutral | Maintains | |
| 2020-01-08 | Wells Fargo | Overweight | Initiate | |
| 2020-01-07 | Citigroup | Neutral | Initiate | |
| 2019-11-26 | UBS | Neutral | Maintains | |
| 2019-11-15 | Stifel Nicolaus | Hold | Initiate | |
| 2019-10-18 | UBS | Buy | Neutral | Downgrade |
| 2019-10-09 | Barclays | Equal-Weight | Maintains | |
| 2019-07-16 | Bank of America | Buy | Neutral | Downgrade |
| 2019-07-15 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2019-06-11 | Piper Jaffray | Overweight | Initiate | |
| 2019-05-15 | Deutsche Bank | Buy | Maintains | |
| 2019-05-15 | Barclays | Overweight | Maintains | |
| 2019-05-15 | Bank of America | Buy | Maintains | |
| 2019-03-26 | Cowen & Co. | Outperform | Outperform | Maintains |
| 2019-03-15 | UBS | Buy | Initiate | |
| 2019-02-21 | Barclays | Overweight | Overweight | Maintains |
| 2019-02-12 | Deutsche Bank | Buy | Buy | Maintains |
| 2019-01-03 | Needham | Buy | Initiate | |
| 2018-11-20 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-10 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-08-15 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-08-15 | Deutsche Bank | Buy | Buy | Maintains |
| 2018-05-15 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2018-04-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-02-15 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-01-04 | Evercore ISI Group | Outperform | Initiate | |
| 2017-11-14 | Morgan Stanley | Overweight | Maintains | |
| 2017-10-09 | Bank of America | Buy | Maintains | |
| 2017-10-06 | Morgan Stanley | Overweight | Maintains | |
| 2017-09-18 | Baird | Outperform | Maintains | |
| 2017-08-23 | Deutsche Bank | Hold | Maintains | |
| 2017-08-16 | Morgan Stanley | Overweight | Maintains | |
| 2017-08-16 | Jefferies | Buy | Maintains | |
| 2017-08-16 | Bank of America | Equal-Weight | Maintains | |
| 2017-07-13 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2017-07-10 | Morgan Stanley | Overweight | Maintains | |
| 2017-03-15 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2017-01-04 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2016-08-18 | Goldman Sachs | Buy | Maintains | |
| 2016-08-18 | Evercore ISI Group | Buy | Maintains | |
| 2016-08-18 | Cowen & Co. | Outperform | Maintains | |
| 2016-08-18 | BTIG Research | Buy | Maintains | |
| 2016-08-18 | Baird | Outperform | Maintains | |
| 2016-05-26 | Cowen & Co. | Outperform | Maintains | |
| 2016-05-11 | Goldman Sachs | Buy | Maintains | |
| 2016-02-17 | Deutsche Bank | Hold | Maintains | |
| 2016-02-17 | Barclays | Equal-Weight | Maintains | |
| 2016-02-17 | Bank of America | Equal-Weight | Maintains | |
| 2016-02-17 | Baird | Outperform | Maintains | |
| 2016-01-07 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2016-01-06 | Deutsche Bank | Hold | Initiate | |
| 2015-12-09 | Baird | Neutral | Outperform | Upgrade |
| 2015-12-08 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2015-11-17 | Barclays | Equal-Weight | Maintains | |
| 2015-05-29 | Jefferies | Buy | Maintains | |
| 2015-05-19 | Baird | Neutral | Maintains | |
| 2015-03-10 | UBS | Neutral | Initiate | |
| 2015-02-25 | BTIG Research | Neutral | Buy | Upgrade |
| 2015-01-07 | Citigroup | Neutral | Maintains | |
| 2014-11-18 | JP Morgan | Overweight | Maintains | |
| 2014-11-04 | Citigroup | Neutral | Maintains | |
| 2014-11-04 | Bank of America | Buy | Maintains | |
| 2014-10-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2014-10-20 | Bank of America | Buy | Maintains | |
| 2014-10-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2014-10-03 | BTIG Research | Neutral | Initiate | |
| 2014-09-08 | Morgan Stanley | Equal-Weight | Initiate | |
| 2014-05-15 | Bank of America | Buy | Maintains | |
| 2014-05-12 | Jefferies | Buy | Maintains | |
| 2014-02-17 | JP Morgan | Overweight | Maintains | |
| 2014-01-06 | Morgan Stanley | Overweight | Maintains | |
| 2013-12-12 | Bank of America | Buy | Maintains | |
| 2013-11-15 | Citigroup | Buy | Maintains | |
| 2013-10-01 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2013-09-20 | Morgan Stanley | Overweight | Maintains | |
| 2013-09-20 | Barclays | Overweight | Maintains | |
| 2013-09-19 | Janney Capital | Neutral | Buy | Upgrade |
| 2013-09-19 | ISI Group | Buy | Strong Buy | Upgrade |
| 2013-08-15 | Stifel Nicolaus | Buy | Maintains | |
| 2013-08-15 | Longbow Research | Buy | Maintains | |
| 2013-08-15 | Jefferies | Buy | Maintains | |
| 2013-08-15 | Janney Capital | Neutral | Initiate | |
| 2013-08-15 | Citigroup | Buy | Maintains | |
| 2013-08-15 | Barclays | Overweight | Maintains | |
| 2013-06-25 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2013-05-15 | Stifel Nicolaus | Buy | Maintains | |
| 2013-05-15 | ISI Group | Buy | Maintains | |
| 2013-03-08 | Bank of America | Buy | Maintains | |
| 2013-03-06 | Leerink Swann | Outperform | Initiate | |
| 2013-03-05 | Credit Suisse | Outperform | Initiate | |
| 2013-02-15 | UBS | Buy | Maintains | |
| 2013-02-15 | S&P Capital IQ | Hold | Sell | Downgrade |
| 2013-02-15 | JP Morgan | Overweight | Maintains | |
| 2013-02-15 | Barclays | Overweight | Maintains | |
| 2013-02-12 | UBS | Buy | Maintains | |
| 2013-01-17 | CLSA | Buy | Outperform | Downgrade |
| 2012-11-20 | Stifel Nicolaus | Buy | Maintains | |
| 2012-11-20 | Jefferies | Buy | Maintains | |
| 2012-11-20 | Barclays | Overweight | Maintains | |
| 2012-11-19 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2012-10-16 | Citigroup | Buy | Maintains | |
| 2012-08-16 | UBS | Buy | Maintains | |
| 2012-08-16 | Morgan Stanley | Overweight | Maintains | |
| 2012-08-16 | JP Morgan | Overweight | Maintains | |
| 2012-08-16 | Jefferies | Buy | Maintains | |
| 2012-08-16 | ISI Group | Overweight | Maintains | |
| 2012-08-16 | Citigroup | Buy | Maintains | |
| 2012-08-16 | Barclays | Overweight | Maintains | |
| 2012-08-13 | Jefferies | Buy | Maintains | |
| 2012-07-23 | Citigroup | Buy | Maintains | |
| 2012-07-10 | ISI Group | Overweight | Initiate | |
| 2012-05-15 | Stifel Nicolaus | Buy | Maintains | |
| 2012-05-15 | Morgan Stanley | Overweight | Maintains | |
| 2012-04-19 | Stifel Nicolaus | Buy | Maintains | |
| 2012-03-06 | Morgan Stanley | Overweight | Initiate | |
| 2012-02-16 | Deutsche Bank | Buy | Maintains | |
| 2023-03-01 | Baird | Outperform | Maintains | |
| 2023-03-01 | Credit Suisse | Outperform | Maintains | |
| 2023-05-24 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2023-05-24 | SVB Securities | Outperform | Maintains | |
| 2023-05-24 | Credit Suisse | Outperform | Outperform | Maintains |
| 2023-05-24 | TD Cowen | Outperform | Outperform | Maintains |
| 2023-05-24 | B of A Securities | Buy | Buy | Maintains |
| 2023-05-24 | Goldman Sachs | Buy | Buy | Maintains |
| 2023-05-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-05-24 | Stifel | Hold | Hold | Maintains |
| 2023-05-24 | Baird | Outperform | Outperform | Maintains |
| 2023-05-11 | Barclays | Equal-Weight | Initiate | |
| 2023-05-24 | Citigroup | Neutral | Neutral | Maintains |
| 2023-05-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-05-24 | Keybanc | Overweight | Sector Weight | Downgrade |
| 2023-08-16 | Jefferies | Buy | Buy | Maintains |
| 2023-08-16 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-01-25 | Barclays | Underweight | Underweight | Maintains |
| 2023-11-22 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-12-20 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-07-31 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2024-06-03 | Jefferies | Buy | Hold | Downgrade |
| 2024-05-31 | Barclays | Underweight | Underweight | Maintains |
| 2023-07-31 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2023-12-13 | Wolfe Research | Outperform | Initiate | |
| 2023-11-17 | UBS | Buy | Neutral | Downgrade |
| 2023-09-28 | Bernstein | Market Perform | Initiate | |
| 2023-09-29 | Barclays | Underweight | Underweight | Maintains |
| 2023-08-16 | TD Cowen | Outperform | Outperform | Maintains |
| 2023-08-16 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-08-16 | Baird | Outperform | Outperform | Maintains |
| 2023-08-16 | Credit Suisse | Outperform | Outperform | Maintains |
| 2023-08-16 | Barclays | Underweight | Underweight | Maintains |
| 2023-12-07 | Goldman Sachs | Buy | Buy | Maintains |
| 2023-11-21 | Baird | Outperform | Outperform | Maintains |
| 2023-12-12 | B of A Securities | Buy | Neutral | Downgrade |
| 2024-02-28 | Barclays | Underweight | Underweight | Maintains |
| 2024-02-28 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-02-28 | UBS | Neutral | Neutral | Maintains |
| 2024-02-28 | Citigroup | Neutral | Neutral | Maintains |
| 2024-05-30 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-05-30 | UBS | Neutral | Neutral | Maintains |
| 2024-05-30 | B of A Securities | Neutral | Neutral | Reiterate |
| 2024-05-30 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-05-30 | TD Cowen | Buy | Buy | Maintains |
| 2024-05-30 | Citigroup | Neutral | Neutral | Maintains |
| 2024-05-30 | Stifel | Buy | Buy | Maintains |
| 2024-05-30 | Baird | Outperform | Outperform | Maintains |
| 2024-04-10 | Barclays | Underweight | Underweight | Maintains |
| 2024-03-26 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-04-05 | Stifel | Hold | Buy | Upgrade |
| 2024-04-04 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-02 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-06-27 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2024-07-10 | Citigroup | Neutral | Buy | Upgrade |
| 2024-06-25 | B of A Securities | Neutral | Neutral | Maintains |
| 2025-02-27 | Baird | Outperform | Outperform | Maintains |
| 2024-08-27 | Wells Fargo | Overweight | Initiate | |
| 2025-06-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-28 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-11-27 | Barclays | Underweight | Underweight | Maintains |
| 2024-11-26 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-11-26 | Bernstein | Market Perform | Market Perform | Maintains |
| 2024-08-22 | Citigroup | Buy | Buy | Maintains |
| 2024-08-22 | TD Cowen | Buy | Buy | Maintains |
| 2024-08-22 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-08-22 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-12-13 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-08-23 | Barclays | Underweight | Underweight | Maintains |
| 2024-08-22 | UBS | Neutral | Neutral | Maintains |
| 2025-02-10 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2024-12-09 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-01 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2025-08-28 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-28 | Baird | Outperform | Outperform | Maintains |
| 2024-10-15 | Barclays | Underweight | Underweight | Maintains |
| 2025-05-29 | UBS | Neutral | Neutral | Maintains |
| 2025-05-29 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-04-21 | Jefferies | Hold | Hold | Maintains |
| 2025-04-17 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-05-22 | Baird | Outperform | Outperform | Maintains |
| 2025-04-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-29 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
